
Hybrid nanoparticles restore blood-clotting activity
Conjugating peptides with heparin-binding activity to nanoparticles could lead to a safer drug for reversing heparin activity
Thank you for registering with Physics World
If you'd like to change your details at any time, please visit My account
Theodora Bruun is a graduate student contributor to Physics World, working in biochemistry and protein engineering at the University of Oxford. She is interested in the fields of nanotechnology and medicine. She is half-Finnish and half-Bulgarian but has spent most of her life in Canada. She spent 13 years as a competitive gymnast but now stays active by rowing, biking and rock-climbing. When not in the lab, Theodora is an avid reader of fiction, a film enthusiast and a big animal lover (despite her allergies to fur).
Conjugating peptides with heparin-binding activity to nanoparticles could lead to a safer drug for reversing heparin activity
Towards a vaccine for Alzheimer's disease. Researchers at Cinvestav in Mexico have produced a promising vaccine candidate against Alzheimer's disease by targeting the amyloid-beta (Aβ) peptide
A study of non-responsive breast tumours reveals changes in vasculature that may help scientists develop therapies for evasive tumours
Nanocages treated with a unique polymer coating can penetrate lung tumours and airway mucus layers to deliver drugs for targeted treatment
Physics World is now offering early-career scientists the opportunity to work alongside our award-winning journalism team to write and publish news stories for the global scientific community.
We provide training and mentorship to graduate students who are eager to write about the most exciting new research results, and offer them the opportunity to publish their work on a site that’s read by professional scientists all over the world.
Sounds interesting? Find out how you can get involved.